8 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... (DOACS + Warfarin ... #DOAC #Dosing #Oral ... #Table #Pharmacology
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
phosphate binding agents ... since they are ... not able to effectively ... levels toward the normal ... #Dosing #Pharmacology
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
to six months are ... valves since these agents ... patients with chronic atrial ... #Management #Cardiology ... #Table #Replacement
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Atrial Fibrillation ... of or increased doses ... with digoxin, are ... management #treatment #comparison ... #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
sx overlap with normal ... Avoid Warfarin and DOAC ... Delivery • Stable ... Serial TTE and close ... diagnosis #management #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... neuroexam - Oral ... ACEi/ARBs - Hold ... one post op Cardiology ... CARP, DECREASE V trials
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
adjusting the dose ... transitioning to oral ... algorithm #management #cardiology ... #treatment #table ... icu #clinical #pharmacology